Stock Screener
Show:
Sort
Country
Sector
Risk rating
1
2
3
4
5
6
7
Risk factors
Default risk
1
2
3
4
5
6
7
Volatility
1
2
3
4
5
6
7
Stress test
1
2
3
4
5
6
7
Selling difficulty
1
2
3
4
5
6
7
Country risks
1
2
3
4
5
6
7
Other risks
1
2
3
4
5
6
7
Profitability factors
Valuation
1
2
3
4
5
6
7
Analyst view
1
2
3
4
5
6
7
Performance
1
2
3
4
5
6
7
Profitability
1
2
3
4
5
6
7
Growth
1
2
3
4
5
6
7
Dividends
1
2
3
4
5
6
7
Results: 13
UCB S.A.
UCB.BRFinancière de Tubize S.A.
TUB.BRGalapagos NV
GLPGFagron NV
FAGR.BRIon Beam Applications SA
IBAB.BRMDxHealth SA
MDXHNyxoah SA
NYXHHyloris Pharmaceuticals SA
HYL.BRCelyad Oncology SA
CYAD.BROxurion N.V.
OXUR.BREuropean Medical Solutions
ALEMS.BRbonyf N.V.
MLBON.PAAgomAb Therapeutics NV
AGMB
Return for Q2 2026:-7.3%
Portfolio composition:
Return for Q2 2026:10.41%
Portfolio composition: